Article List

WPRIM Management System> DCMS> Asian Journal of Andrology> 2009> 11> 1

Volume: 11 Issue: 1

1. Stroma-epithelium crosstalk in prostate cancer.	Page:28—35
2. Editorial and introduction to Asian Journal of Andrology Prostate Cancer special issue.	Page:6—8
3. The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer.	Page:39—48
4. Neoadjuvant hormonal deprivation for patients undergoing radical prostatectomy.	Page:127—130
5. Age-specific PSA reference ranges in Chinese men without prostate cancer.	Page:100—103
6. Prostate cancer: diagnosis and staging.	Page:74—80
7. Identification of new genetic risk factors for prostate cancer.	Page:49—55
8. Molecular markers in prostate cancer. Part I: predicting lethality.	Page:14—21
9. Molecular markers in prostate cancer. Part II: potential roles in management.	Page:22—27
10. Outcomes after robot-assisted laparoscopic radical prostatectomy.	Page:94—99
11. The current status of robot-assisted radical prostatectomy.	Page:90—93
12. The androgen receptor in hormone-refractory prostate cancer.	Page:69—73
13. Diagnostic strategies and the incidence of prostate cancer: reasons for the low reported incidence of prostate cancer in China.	Page:9—13
14. Molecular mechanisms of metastasis in prostate cancer.	Page:57—67
15. Management of locally advanced prostate cancer.	Page:81—87
16. Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.	Page:104—108
17. Utility of tissue microarrays for profiling prognostic biomarkers in clinically localized prostate cancer: the expression of BCL-2, E-cadherin, Ki-67 and p53 as predictors of biochemical failure after radical prostatectomy with nested control for clinical and pathological risk factors.	Page:109—118
18. Small ubiquitin-like modifier protein-specific protease 1 and prostate cancer.	Page:36—38
19. Correlations between age, Charlson score and outcome in clinical unilateral T3a prostate cancer.	Page:131—137
20. Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells.	Page:119—126